S&P 500
(0.82%) 5 059.63 points
Dow Jones
(0.78%) 38 198 points
Nasdaq
(1.36%) 15 818 points
Oil
(0.39%) $79.31
Gas
(5.28%) $2.03
Gold
(0.27%) $2 317.20
Silver
(0.69%) $26.93
Platinum
(1.22%) $966.55
USD/EUR
(-0.06%) $0.932
USD/NOK
(-0.36%) $10.99
USD/GBP
(-0.03%) $0.798
USD/RUB
(-1.40%) $91.96

Realaus laiko atnaujinimai Integrated BioPharma, [INBP]

Birža: PNK Pramonė: Packaged Foods
Upcoming Earnings Alert

4 days till quarter result
(tns 2024-05-06)

Expected move: +/- 0.00%

Atnaujinta30 bal. 2024 @ 22:48

0.00% $ 0.210

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 22:48):

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...

Stats
Šios dienos apimtis 2 249.00
Vidutinė apimtis 2 921.00
Rinkos kapitalizacija 6.32M
EPS $0 ( 2024-02-12 )
Kita pelno data ( $0 ) 2024-05-06
Last Dividend $0.500 ( 2008-08-19 )
Next Dividend $0 ( N/A )
P/E -10.50
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-11-28 Riva Sheppard Buy 150 000 Stock Option (right to buy)
2023-11-28 Kay Christina Buy 150 000 Stock Option (right to buy)
2023-11-28 Masi Dina Buy 150 000 Stock Option (right to buy)
2023-03-20 Kay E Gerald Sell 150 000 Stock Option (right to buy)
2023-03-20 Kay E Gerald Sell 100 000 Stock Option (right to buy)
INSIDER POWER
84.17
Last 98 transactions
Buy: 38 374 999 | Sell: 953 334

Integrated BioPharma, Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Integrated BioPharma, Finansinės ataskaitos

Annual 2023
Pajamos: $50.67M
Bruto pelnas: $4.06M (8.01 %)
EPS: $-0.00110
FY 2023
Pajamos: $50.67M
Bruto pelnas: $4.06M (8.01 %)
EPS: $-0.00110
FY 2023
Pajamos: $0
Bruto pelnas: $0 (0.00 %)
EPS: $0
FY 2022
Pajamos: $56.25M
Bruto pelnas: $6.55M (11.65 %)
EPS: $0.130

Financial Reports:

No articles found.

Integrated BioPharma, Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Integrated BioPharma, Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.86 - low (50.00%) | Divividend Growth Potential Score: 0.768 - No dividend growth expected in the near future
Information
First Dividend $0.500 2008-08-19
Last Dividend $0.500 2008-08-19
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.500 --
Avg. Dividend % Per Year 0.00% --
Score 0.55 --
Div. Sustainability Score 2.86
Div.Growth Potential Score 0.768
Div. Directional Score 1.816 --
Next Divdend (Est)
(2024-05-02)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.55
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for PNK

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
FULO Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
EMYB Ex Dividend Knight 2023-06-29 Annually 0 0.00%
CBKM Ex Dividend Knight 2023-08-18 Quarterly 0 0.00%
TNCAF Ex Dividend Junior 2023-08-30 Quarterly 0 0.00%
RSKIA Ex Dividend Knight 2023-09-28 Annually 0 0.00%
NIPNF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
FMCB Ex Dividend Knight 2023-06-08 Semi-Annually 0 0.00%
CSBB Ex Dividend Knight 2023-09-01 Quarterly 0 0.00%
WCRS Ex Dividend Junior 2023-08-21 Quarterly 0 0.00%
BABB Ex Dividend King 2023-09-27 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.006151.500-0.123-0.185[0 - 0.5]
returnOnAssetsTTM-0.01501.200-0.499-0.599[0 - 0.3]
returnOnEquityTTM-0.02051.500-1.339-2.01[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.930.8000.3720.298[1 - 3]
quickRatioTTM0.7650.800-0.203-0.162[0.8 - 2.5]
cashRatioTTM0.1251.500-0.414-0.621[0.2 - 2]
debtRatioTTM0.0884-1.5008.53-10.00[0 - 0.6]
interestCoverageTTM-27.321.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM0.009422.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.008292.0010.0010.00[0 - 20]
debtEquityRatioTTM0.122-1.5009.51-10.00[0 - 2.5]
grossProfitMarginTTM0.05351.000-2.44-2.44[0.2 - 0.8]
operatingProfitMarginTTM-0.01091.000-2.22-2.22[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1251.000-0.419-0.419[0.2 - 2]
assetTurnoverTTM2.430.80010.008.00[0.5 - 2]
Total Score2.86

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-16.421.000-1.7590[1 - 100]
returnOnEquityTTM-0.02052.50-0.861-2.01[0.1 - 1.5]
freeCashFlowPerShareTTM0.008292.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.009422.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.1021.500-4.010[0.5 - 2]
operatingCashFlowSalesRatioTTM0.004531.000-2.390[0.1 - 0.5]
Total Score0.768

Integrated BioPharma,

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.